Back

Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations

Ruttenberg, S. M.; Dhaoui, R.; Kreutzer, A. G.; Nowick, J. S.

2025-05-21 neuroscience
10.1101/2025.05.16.654602 bioRxiv
Show abstract

Anti-A{beta} antibodies are important tools for identifying structural features of aggregates of the A{beta} peptide and are used in many aspects of Alzheimers disease (AD) research. Our laboratory recently reported the generation of a polyclonal antibody, pAb2AT-L, that is moderately selective for oligomeric A{beta} over monomeric and fibrillar A{beta} and recognizes the diffuse peripheries of A{beta} plaques in AD brain tissue but does not recognize the dense fibrillar plaque cores. This antibody was generated against 2AT-L, a structurally defined A{beta} oligomer mimic composed of three A{beta}-derived {beta}-hairpins arranged in a triangular fashion and covalently stabilized with three disulfide bonds. In the current study, we set out to determine if pAb2AT-L is neuroprotective against toxic aggregates of A{beta} and found that pAb2AT-L protects human iPSC-derived neurons from A{beta}42-mediated toxicity at molar ratios as low as 1:100 antibody to A{beta}42, with a ratio of 1:25 almost completely rescuing cell viability. Few other antibodies have been reported to exhibit neuroprotective effects at such low ratios of antibody to A{beta}. ThT and TEM studies indicate that pAb2AT-L delays but does not completely inhibit A{beta}42 fibrillization at sub-stoichiometric ratios. The ability of pAb2AT-L to inhibit A{beta}42 toxicity and aggregation at sub-stoichiometric ratios suggests that pAb2AT-L binds toxic A{beta}42 oligomers and does not simply sequester monomeric A{beta}42. These results further suggest that toxic oligomers of A{beta}42 share significant structural similarities with 2AT-L. TOC Graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/654602v1_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@d97c84org.highwire.dtl.DTLVardef@7dd416org.highwire.dtl.DTLVardef@ef072borg.highwire.dtl.DTLVardef@bfd614_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
ACS Chemical Neuroscience
60 papers in training set
Top 0.1%
23.3%
2
PLOS ONE
4510 papers in training set
Top 26%
6.5%
3
Journal of Biological Chemistry
641 papers in training set
Top 0.2%
5.0%
4
Scientific Reports
3102 papers in training set
Top 21%
5.0%
5
Neurobiology of Disease
134 papers in training set
Top 1%
3.7%
6
ACS Omega
90 papers in training set
Top 0.7%
2.8%
7
Journal of Molecular Biology
217 papers in training set
Top 0.9%
2.7%
8
Journal of the American Chemical Society
199 papers in training set
Top 2%
2.5%
50% of probability mass above
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.8%
10
Journal of Neurochemistry
50 papers in training set
Top 0.1%
1.8%
11
Cells
232 papers in training set
Top 2%
1.8%
12
iScience
1063 papers in training set
Top 13%
1.8%
13
Cell Reports
1338 papers in training set
Top 23%
1.8%
14
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
15
Alzheimer's Research & Therapy
52 papers in training set
Top 1%
1.7%
16
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.4%
17
Life Science Alliance
263 papers in training set
Top 0.6%
1.3%
18
Protein Science
221 papers in training set
Top 1%
1.1%
19
Brain Communications
147 papers in training set
Top 2%
1.1%
20
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.9%
0.9%
21
Frontiers in Neurology
91 papers in training set
Top 5%
0.8%
22
Alzheimer's & Dementia
143 papers in training set
Top 2%
0.8%
23
Alzheimer's & Dementia: Translational Research & Clinical Interventions
16 papers in training set
Top 0.6%
0.8%
24
eLife
5422 papers in training set
Top 58%
0.7%
25
Nature Communications
4913 papers in training set
Top 63%
0.7%
26
Biomolecules
95 papers in training set
Top 2%
0.7%
27
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 1.0%
0.7%
28
The Journal of Physical Chemistry B
158 papers in training set
Top 2%
0.7%
29
Neuroscience
88 papers in training set
Top 3%
0.7%
30
Journal of Medicinal Chemistry
68 papers in training set
Top 1%
0.7%